ARCHIVES

NCI Cooperative Group Clinical Trials Approved

This article is from The Cancer Letter archive.

Vol. 33 No. 10 | October 29, 2010

Download PDF Visit The Full Archive

Related Articles

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

June 30, 2006

Broder Responds To AACR Proposal, Cites Congressional ‘Commitment’

December 6, 1991

In Brief: NCI Awards 4 Contracts For Enrichment Program; Dana-Farber Names Breast Center Leadership

July 10, 1992

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

May 9, 2014

Consensus Panel Determines Total Mastectomy Plus Node Dissection “Satisfactory Alternative” To Radical Mastectomy

June 15, 1979

Results of NSABP Studies Unchanged When Falsified Data is Excluded: Fisher

May 27, 1994